Sector Intelligence · Healthcare Software · June 2026
Healthcare Software Investment 2026
Market data and investment intelligence across healthcare SaaS, clinical decision support, patient engagement platforms and NHS digital transformation — for investors and family offices.
Market Data
The Numbers Shaping Healthcare Software in 2026
$18.4bn
UK digital health market size in 2026, projected to reach $43.98 billion by 2031 at a CAGR of 19.10%.
Source: Mordor Intelligence February 2026
59.2%
Share of UK digital health market revenue accounted for by software in 2025.
Source: Mordor Intelligence 2026
$12.98bn
UK healthcare IT market size in 2025, projected to reach $25.8 billion by 2034 at a CAGR of 7.70%.
Source: IMARC Group 2026
21.3%
Projected CAGR of diagnostics and decision support applications within UK digital health through 2031 — the fastest-growing application segment.
Source: Mordor Intelligence 2026
Investment Landscape
The Healthcare Software Market in 2026
The UK digital health market is driven by sustained NHS investment in electronic patient records, fast-growing virtual ward capacity, the expanding user base of the NHS App and an emerging wave of AI-enabled analytics that optimise care pathways.
The fragmentation of the UK healthcare back-office is an arbitrage opportunity, with private equity expected to be the most active buyer in the sub-$50 million deal bracket. Technologies that automate administrative tasks — revenue cycle management, ambient clinical intelligence — will see faster NHS adoption than complex clinical decision support tools.
AI is the defining investment theme in healthcare software in 2026. AI-powered analytics and predictive healthcare tools are improving clinical decision-making, diagnostics and patient management, while healthcare organisations are increasingly shifting to cloud-based platforms.
What Investors Are Targeting
Assets Attracting Capital in Healthcare Software
AI-Enabled Clinical Tools
AI clinical decision support, ambient documentation, diagnostic AI and population health analytics are commanding premium valuations. The Huma AI platform — backed by AstraZeneca and Bayer — is among the highest-profile European healthcare AI investments, having raised $300 million in total and announced an M&A acceleration partnership with Eckuity Capital.
NHS Digital Transformation
Investments that facilitate the movement of care from hospital to home — remote patient monitoring, community diagnostics, digital therapeutics — have a structural tailwind aligned with the NHS 10-Year Plan.
Healthcare SaaS Platforms
Recurring-revenue SaaS businesses serving hospitals, GP practices, pharmacy networks and specialist care providers — particularly those with NHS contract frameworks, high switching costs and expanding product suites — are consistently attractive to both growth equity and buyout investors.
Key Risks
Risks for Healthcare Software Investors in 2026
- NHS procurement cycles are long and complex — commercial timelines often slower than non-healthcare SaaS comparables
- Cybersecurity risk is escalating: criminals are using AI to launch more sophisticated attacks on interconnected health systems
- MHRA Software as a Medical Device (SaMD) regulatory classification requirements creating compliance costs for AI clinical tools
- NHS budget constraints and integrated care system restructuring creating revenue uncertainty
Subscribe
Stay Informed on Healthcare Investment
Subscribe to Healthcare Investor Magazine — independent investment intelligence for investors, family offices and private wealth owners.
FAQs
Frequently Asked Questions
Related Sectors
Explore Other Investment Sectors
Published for informational purposes only. Does not constitute financial or investment advice. All data sourced from primary institutional sources as cited. Seek independent professional advice before making any investment decision.
Healthcare Software Investment UK — Why HCIT Is the Priority Sector
Healthcare software and health information technology has emerged as the priority M&A and investment sector for private equity in UK healthcare — driven by the combination of NHS digital transformation mandates, high switching costs once deployed, recurring SaaS revenue models and the AI integration roadmap that makes every established HCIT platform a potential AI-enabled asset. PwC's Global M&A Health Industries Outlook 2026 identifies AI-based telehealth, revenue cycle management, workforce optimisation and utilisation management platforms as priority acquisition targets. The UK digital health market is growing at 19.1% CAGR, according to Mordor Intelligence 2026. NHS Supply Chain's commitment to Value-Based Procurement — now formally confirmed with a 40/60 scoring split weighting health outcomes over price — is accelerating the commercial opportunity for HCIT platforms that can demonstrate patient outcome data in a format suitable for procurement evaluation. Healthcare Investor Magazine tracks UK healthcare software and HCIT investment as a dedicated coverage area — including acquisitions, funding rounds, NHS contract awards and technology partnership announcements across the full digital health stack.